REFERENCES
-
1
Ribeiro A, Burgart L J, Nagorney D M, Gores G J.
Management of liver adenomatosis: results with a conservative surgical approach.
Liver Transpl Surg.
1998;
4
388-398
-
2
Chiche L, Dao T, Salame E et al..
Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature.
Ann Surg.
2000;
231
74-81
-
3
Boyd P R, Mark G J.
Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years.
Cancer.
1977;
40
1765-1770
-
4
Sale G E, Lerner K G.
Multiple tumors after androgen therapy.
Arch Pathol Lab Med.
1977;
101
600-603
-
5
Howell R R, Stevenson R E, Ben-Menachem Y, Phyliky R L.
Hepatic adenomata with type 1 glycogen storage disease.
JAMA.
1976;
236
1481-1484
-
6
Monaco A P, Hallgrimsson J, McDermott W V.
Multiple adenoma (hamartoma) of the liver treated by subtotal (90%) resection: morphological and functional studies of regeneration.
Ann Surg.
1964;
159
513-519
-
7
Brander W L, Vosnides G, Ogg C S, West I E.
Multiple hepatocellular tumours in a patient treated with oral contraceptives.
Virchows Arch A Pathol Anat Histol.
1976;
370
69-76
-
8
Edmondson H A, Reynolds T B, Henderson B, Benton B.
Regression of liver cell adenomas associated with oral contraceptives.
Ann Intern Med.
1977;
86
180-182
-
9
Foster J H, Donohue T A, Berman M M.
Familial liver cell adenomas and diabetes mellitus.
N Engl J Med.
1978;
299
239-241
-
10
Kalra P A, Guthrie J A, Dibble J B, Turney J H, Brownjohn A M.
Hepatic adenomas induced by norethisterone in patients receiving renal dialysis.
Br Med J (Clin Res Ed).
1987;
294
808
-
11
Liu A FK, Hiratzka L F, Hirose F M.
Multiple adenomas of the liver.
Cancer.
1980;
45
1001-1004
-
12
Sinha M R, Prasad S B.
Multiple adenomas of the liver.
J Indian Med Assoc.
1982;
79
16-18
-
13
Chen K TK, Bocian J J.
Multiple hepatic adenomas (letter).
Arch Pathol Lab Med.
1983;
107
274-275
-
14
Le Bail B, Jouhanole H, Deugnier Y et al..
Liver adenomatosis with granulomas in two patients on long-term oral contraceptives.
Am J Surg Pathol.
1992;
16
982-987
-
15
Propst A, Propst T, Waldenberger P, Vogel W, Judmaier G.
A case of hepatocellular adenomatosis with a follow-up of 11 years.
Am J Gastroenterol.
1995;
90
1345-1346
-
16
Gokhale R, Whitington P F.
Hepatic adenomatosis in an adolescent.
J Pediatr Gastroenterol Nutr.
1996;
23
482-486
-
17
Arsenault T M, Johnson C D, Gorman B, Burgart L J.
Hepatic adenomatosis.
Mayo Clin Proc.
1996;
71
478-480
-
18
Ye M Q, Suwinata A, Hain M B, Parsons R, Schwartz M.
A 42 year old woman with liver masses and long-term use of oral contraceptives.
Semin Liver Dis.
1999;
19
339-344
-
19
Suarez A A, Brunt E M, Di Bisceglie A M.
A 35 year old woman with progesterone implant contraception and multiple liver masses.
Semin Liver Dis.
2001;
21
453-459
-
20
Flejou J F, Barge J, Menu Y et al..
Liver adenomatosis. An entity distinct from liver adenoma?.
Gastroenterology.
1985;
89
1132-1138
-
21
Leese T, Farges O, Bismuth H.
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.
Ann Surg.
1988;
208
558-564
-
22
Yoshidome H, McMasters K M, Edwards M J.
Management issues regarding hepatic adenomatosis.
Am Surg.
1999;
65
1070-1076
-
23
Grazioli L, Federle M P, Ichikawa T, Balzano E, Nalesnik M, Madariaga J.
Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients.
Radiology.
2000;
216
395-402
-
24
Bluteau O, Jeannot E, Bioulac-Sage P et al..
Bi-allelic inactivation of TCF1 in hepatic adenomas.
Nat Genet.
2002;
32
312-315
-
25
Bacq Y, Jacquemin E, Balabaud C et al..
Familial liver adenomatosis associated with hepatocyte nuclear factor 1α inactivation.
Gastroenterology.
2003;
125
1470-1474
-
26
Cotrim H P, Parana R, Braga E, Lyra L.
Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?.
Am J Gastroenterol.
2000;
95
3018-3019
-
27
Ludwig J, McGill D B, Lindor K D.
Nonalcoholic steatohepatitis.
J Gastroenterol Hepatol.
1997;
12
398-403
-
28
Orikasa H, Ohyama R, Tsukada N, Eyden B P, Yamazaki K.
Lipid-rich clear-cell carcinoma arising in nonalcoholic steatohepatitis in a patient with diabetes mellitus.
J Submicrosc Cytol Pathol.
2001;
33
195-200
-
29
Powell E E, Cooksley W G, Hanson R, Searle J, Halliday J W, Powell L W.
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
Hepatology.
1990;
11
74-80
-
30
Shimada M, Hashimoto E, Taniai M et al..
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
J Hepatol.
2002;
37
154-160
-
31
Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y.
Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
Pathol Int.
2001;
51
127-131
-
32
Brunt E M.
Benign tumors of the liver.
Clin Liver Dis.
2001;
5
1-15
-
33
Calle E E, Rodriguez C, Walker-Thurmond K, Thun M J.
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
N Engl J Med.
2003;
348
1625-1638
-
34
Balkau B, Kahn H S, Courbon D, Eschwege E, Ducimetiere P.
Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites.
Diabetes Care.
2001;
24
843-849
-
35
Nair S, Mason A, Eason J, Loss G, Perillo R P.
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?.
Hepatology.
2002;
36
150-155
-
36
Lagiou P, Kuper H, Stuver S O, Tzonou A, Trichopoulos D, Adami H O.
Role of diabetes mellitus in the etiology of hepatocellular carcinoma.
J Natl Cancer Inst.
2000;
92
1096-1099
-
37
El-Serag H B, Tran T, Everhart J E.
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.
Gastroenterology.
2004;
126
460-468
-
38
Marchesini G, Bugianesi E, Forlani G et al..
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Hepatology.
2003;
37
917-923
-
39
Bugianesi E, Leone N, Vanni E et al..
Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
Gastroenterology.
2002;
123
134-140
-
40
Ratziu V, Bonyhay L, Di Martino V et al..
Survival, liver failure and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
Hepatology.
2002;
35
1485-1493
-
41
Marrero J A, Fontana R J, Su G L, Conjeevaram H S, Emick D M, Lok A S.
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.
Hepatology.
2002;
36
1349-1354
-
42
Clark J M, Brancati F L, Diehl A M.
Nonalcoholic fatty liver disease.
Gastroenterology.
2002;
122
1649-1657
-
43
Ruhl C E, Everhart J E.
Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.
Gastroenterology.
2003;
124
71-79
Elizabeth M BruntM.D.
Professor of Pathology, 4th Floor, FDT, SLUH
3635 Vista Avenue, St. Louis, MO 63110
eMail: bruntem@slu.edu
